Trust is key in any clinical trial, especially post COVID-19. How can this trust be developed, and why is it integral to ensuring the success of the trial.
An article written by Clare Wallis, President, Oncology Business Unit, Worldwide Clinical Trials, and Worldwide customer Teleen Norman, Senior Vice President, Clinical Operations, Xilio Therapeutics.
